Sickle cell breakthrough: World's first CRISPR therapy cures Louisiana man's lifelong disease

A 23-year-old man from Louisiana has become one of the first people in the United States to be functionally cured of sickle cell disease using Casgevy, the world's first approved CRISPR-based gene-editing therapy. Daniel Cressy, from Metairie near New Orleans, had lived with the inherited blood disorder since childhood, enduring severe pain crises and repeated hospitalisations.

Raccontata datimesofindia.indiatimes.com